Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
A 48-week Phase 2 trial reported in The Lancet in 2025 showed mean weight reduction ranging from approximately 9% at the lowest dose to 20% at the highest dose, compared with 0.4% on placebo
As for body composition or weight changes, there are peptides that are proven to help many people reduce weight: GLP-1s
While we need more research on how BPC-157 may support liver health in a therapeutic setting, we have some promising results so far
However, individuals who have type 2 diabetes alongside a need to minimise weight gain or promote weight loss may benefit from GLP-1/GIP therapy and its dual impact on type 2 diabetes management and weight loss
Johanson JF, Kralstein J
Nov 2019;22(6):418-424
US$ 24.09
US$ 29.14
US$ 25.89
US$ 28.48
US$ 26.42
